Attached files

file filename
EX-32.2 - EX-32.2 - Replimune Group, Inc.repl-63021x10qxex322.htm
EX-31.2 - EX-31.2 - Replimune Group, Inc.repl-63021x10qxex312.htm
EX-31.1 - EX-31.1 - Replimune Group, Inc.repl-63021x10qxex311.htm
10-Q - 10-Q - Replimune Group, Inc.repl-20210630.htm

Exhibit 31.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Replimune Group, Inc. (the “Company”) for the quarter ended June 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Philip Astley-Sparke, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 6, 2021By:/s/ Philip Astley-Sparke
Philip Astley-Sparke
Chief Executive Officer
(Principal Executive Officer)